CD115− monocytic MDSCs, functionally distinct from CD115+ monocytic MDSCs, increase in the blood and bone marrow as tumor progresses and can give rise to OLFM4hi polymorphonuclear MDSCs outside the tumor mass. This evidence concerns the gene CSF1R and neoplasm.